NCT05750199

Brief Summary

This study is a 2-year qualitative and quantitative mixed method research project and consists of two phases.The study will provide useful clinical data to help us better understand educational needs of immunotherapy for oncology nurses. This ISTC model will lead to further validation of an oncology care training course model designed to better prepare and support cancer patients and their families to existing and new anti-cancer therapies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 28, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 23, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 6, 2022

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 19, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 1, 2023

Completed
Last Updated

August 16, 2023

Status Verified

August 1, 2023

Enrollment Period

7 months

First QC Date

January 6, 2022

Last Update Submit

August 15, 2023

Conditions

Keywords

cancerimmunotherapyoncology nurseeducation needtraining course

Outcome Measures

Primary Outcomes (1)

  • Educational needs

    Oncology nurses' educational needs for immunotherapy will be assesed qualitative method.

    1 time points:first time is before the training course

Secondary Outcomes (3)

  • Communication ability scale

    2 time points: Time 1 (before the training course) ; Time 2 (16 weeks after the training course)

  • Self efficacy scale

    2 time points: Time 1 (before the training course) ; Time 2 (16 weeks after the training course)

  • Critical Thinking test

    2 time points: Time 1 (before the training course) ; Time 2 (16 weeks after the training course)

Study Arms (2)

Immunotherapy Special Training Course (ISTC)

EXPERIMENTAL

16 weeks and includes 8 hours of digital media training and 2 days of workshop training.

Other: Immunotherapy Special Training Course (ISTC)

Advanced Oncology Nurse Training Course (AONTC)

EXPERIMENTAL

4 weeks and includes 8 days of Advanced Oncology Nurse Training Course.

Other: Advanced Oncology Nurse Training Course (AONTC)

Interventions

16 weeks and includes 8 hours of digital media training and 2 days of workshop training.

Immunotherapy Special Training Course (ISTC)

4 weeks and includes 8 days of Advanced Oncology Nurse Training Course

Advanced Oncology Nurse Training Course (AONTC)

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 20 years old (inclusive).
  • Nurses or case managers who have completed the training of oncology nursing courses in their hospitals.
  • Caring experiences of cancer patients who undergoing immunotherapy.
  • The working experience of the oncology unit is at least 1 years.

You may not qualify if:

  • \. Those who are unwilling or unable to participate in the full four-month course training.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University

Taipei, 802, Taiwan

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 6, 2022

First Posted

March 1, 2023

Study Start

April 28, 2021

Primary Completion

November 23, 2021

Study Completion

October 19, 2022

Last Updated

August 16, 2023

Record last verified: 2023-08

Locations